Linked Life Data

3241259

Source:http://linkedlifedata.com/resource/pubmed/id/3241259

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1989-5-18
pubmed:abstractText
It has long been suspected that sodium and potassium intake influence blood pressure. Since both these electrolytes can be modified by diet, attention has focused on decreasing sodium intake and increasing potassium intake as a potential way of treating and preventing hypertension. Several short-term controlled clinical trials have examined the effect of supplemental potassium intake on blood pressure, but with inconsistent results. The Minnesota Mount Sinai Hypertension Trial (MSHT) is a double-blind study comparing placebo with potassium supplementation for controlling blood pressure in hypertensive men on a sodium-restricted diet over a 2-3 year follow-up period. At the time of randomization to placebo or supplemental potassium and through 12 weeks of follow-up, the patients were taking antihypertensive medication. This preliminary report compares blood pressure changes between the placebo and supplemental potassium groups over the first 12 weeks of the trial.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0952-1178
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S591-3
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Effect of potassium supplementation combined with dietary sodium reduction on blood pressure in men taking antihypertensive medication.
pubmed:affiliation
Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis 55455.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't